PATENT CLAIM ANALYSIS

Application Number: 16083624
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["514", "291000"]

Abstract:
The present invention concerns the use of an H4 agonist molecule against histamin, enantiomers of (AMINO-7 TRIETHOXY-4,5,6 OXO-1 DIHYDRO-1,3 ISOBENZOFURANNYL-3)-1 METHOXY-8 METHYL-METHYLENEDIOXY-6,7 TETRAHYDRO-,2,3,4 ISOQUINOLINE or tritoqualine, for the treatment of idiopathic pulmonary fibrosis.

Claim (Index 4):
A substance comprising:\n an agonist activity on the histamine H4 receptor for its use in the treatment of idiopathic pulmonary fibrosis, wherein it is comprised of an isomer or of a mixture of isomers of 7-Amino-4,5,6-triethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl- 1,3 -dioxolo[4,5-g]isoquinolin-5-yl) phthalide, or tritoqualine.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 97.0
- Lexical Diversity: 1.11429
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13648543', '12124494', '15122241', '14883370', '15495806']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.721492625304921
- 35 USC 102 Novelty (BERT): 0.507947509568258
- Combined Prediction Score: 0.7001381137312548
- Mean Citation Score: 179.80354000000003
- Max Citation Score: 183.51843
- Similarity Product: 99.2949904991752

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test